To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Oral Cannabidiol Does Not Reduce Acute Non-traumatic Low Back Pain

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
August 2021

Oral Cannabidiol Does Not Reduce Acute Non-traumatic Low Back Pain

Vol: 64| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

The CANBACK trial: a randomised, controlled clinical trial of oral cannabidiol for people presenting to the emergency department with acute low back pain

Med J Aust. 2021 May;214(8): 370-375.

Contributing Authors:
B Bebee DM Taylor E Bourke K Pollack L Foster M Ching A Wong

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred patients with acute, non-traumatic low back pain presenting to the emergency department were randomized to receive a single-dose of oral cannabidiol (400mg) or placebo in addition to standard emergency department analgesic medication. The primary outcome of interest was pain score two hours after administration of the study agent on a verbal numerical pain scale. Secondary outcomes inc...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.